Expertise in
11
conditions

Riccardo Pofi

Rome, IT 
Expertise in
11
conditions
Rome, IT 

Overview

Riccardo Pofi practices practicing medicine in Rome, Italy.

Mr. Pofi is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Addison's Disease, Cushing's syndrome, Intersex, Hormone Replacement Therapy (HRT), and Orchiectomy.

He is actively involved in clinical research, co-authoring 84 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Rome, 00161, Italy
Other Locations
Sapienza, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Study on New Insights in Remodeling of Endocrine Cardiomyopathies: Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in Cushing's Syndrome
Study on New Insights in Remodeling of Endocrine Cardiomyopathies: Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in Cushing's Syndrome
Enrollment Status: Completed
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Tadalafil
Study Phase: Phase 2
Study on New Insights in Remodeling of Endocrine Cardiomyopathies: ASsessmentt of Intramyocardial, Molecular and NeUroendocrine Parameters in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in AcroMegaly
Study on New Insights in Remodeling of Endocrine Cardiomyopathies: ASsessmentt of Intramyocardial, Molecular and NeUroendocrine Parameters in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in AcroMegaly
Enrollment Status: Completed
Publish Date: May 12, 2023
Intervention Type: Drug
Study Drug: Tadalafil
Study Phase: Phase 2
View 1 Less Clinical Trial

84 Total Publications

Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night.
Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night.
Journal: Cell metabolism
Published: April 03, 2026

Frequently Asked Questions about Riccardo Pofi

Is Riccardo Pofi a top-rated expert for Addison's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Riccardo Pofi is classified as an Distinguished expert for Addison's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Riccardo Pofi participate in research or clinical trials?

Yes. Riccardo Pofi has published 84 articles and abstracts on conditions like Addison's Disease. You can view a list of Riccardo Pofi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pofi's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 38 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile